Company Profiles

driven by the PitchBook Platform

Vaxxas

Description

Developer of a needle-free vaccine delivery system. The company develops and commercializes a vaccine delivery technology which consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device.

2011

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$19.5M

Latest Deal Amount

$35.2M

Total Amount Raised

Description

Developer of a needle-free vaccine delivery system. The company develops and commercializes a vaccine delivery technology which consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device.

Website:

www.vaxxas.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Delivery

Primary Office

Suite 13.02, Level 13 179 Elizabeth Street Sydney, New South Wales 2000Australia
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Vaxxas's full profile, request a free trial.

    Vaxxas Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Vaxxas Investors (6)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Brandon Capital PartnersVenture CapitalMinority000 0000000 0000
    HealthCare VenturesVenture CapitalMinority000 0000000 0000
    OneVenturesVenture CapitalMinority000 0000000 0000
    The Medical Research Commercialisation FundVenture CapitalMinority000 0000000 0000
    Torrey Pines InvestmentVenture CapitalMinority000 0000000 0000
    Brandon Capital Partners Venture Capital
    HealthCare Ventures Venture Capital
    OneVentures Venture Capital
    The Medical Research Commercialisation Fund Venture Capital
    Torrey Pines Investment Venture Capital

    Vaxxas Executive Team (6)

    NameTitleBoard
    Seat
    Contact
    Info
    David HoeyChief Executive Officer & Board Member
    Angus Forster Ph.DChief Development and Operations Officer
    Ian FrazerAdvisor
    Ian RhodesAdvisor
    Julian Hickling Ph.DAdvisor
    David Hoey Chief Executive Officer & Board Member
    Angus Forster Ph.D Chief Development and Operations Officer
    Ian Frazer Advisor
    Ian Rhodes Advisor
    Julian Hickling Ph.D Advisor

    Vaxxas Board Members (7)

    NameRepresentingRoleSinceContact
    Info
    Andrew DenverSelfBoard Member000 0000
    David HoeyVaxxasChief Executive Officer & Board Member000 0000
    Dean Moss Ph.DSelfBoard Member000 0000
    Douglas Onsi JDHealthCare VenturesManaging Director000 0000
    Mark Ashton Ph.DSelfBoard Member000 0000
    Andrew Denver Board Member Self
    David Hoey Chief Executive Officer & Board Member Vaxxas
    Dean Moss Ph.D Board Member Self
    Douglas Onsi JD Managing Director HealthCare Ventures
    Mark Ashton Ph.D Board Member Self
    Request full access to PitchBook